The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Galectin Therapeutics Inc

Nasdaq: GALTW
Last

(U.S.) $0.16

Today's change-0.03 -15.79%
Updated February 22 10:29 AM -5GMT. Delayed by at least 15 minutes.
 

Galectin Therapeutics Inc

Nasdaq: GALTW
Last

(U.S.) $0.16

Today's change-0.03 -15.79%
Updated February 22 10:29 AM -5GMT. Delayed by at least 15 minutes.

Galectin Therapeutics Inc crosses below 125-day moving average

Galectin Therapeutics Inc is sharply lower today, dropping (U.S.)$0.03 or 15.79% to (U.S.)$0.16 and crossing below its 125-day moving average. Shares have lost 13.51% over the last five days, but have gained 191.97% over the last year to date. This security has underperformed the S&P 500 by 79.12% during the last year.

Key company metrics

  • Open(U.S.) $0.16
  • Previous close(U.S.) $0.19
  • High(U.S.) $0.18
  • Low(U.S.) $0.16
  • Bid / Ask(U.S.) $0.17 / (U.S.) $0.19
  • YTD % change+191.97%
  • Volume9,987
  • Average volume (10-day)19,847
  • Average volume (1-month)30,118
  • Average volume (3-month)14,531
  • 52-week range(U.S.) $0.04 to (U.S.) $0.97
  • Beta--
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS--
Updated February 22 10:29 AM -5GMT. Delayed by at least 15 minutes.

Latest Company News

    No News Results.

Latest Press Releases

    No Press Release Results.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue--0----
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense5675
Selling / general / administrative1122
Research & development3443
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-5-6-7-5
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-5-6-7-5
Income after tax-5-6-7-5
Income tax, total--------
Net income-5-6-7-5
Total adjustments to net income-1000
Net income before extra. items-5-6-7-5
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-6-6-7-5
Inc. avail. to common incl. extra. items-6-6-7-5
Diluted net income-6-6-7-5
Dilution adjustment--------
Diluted weighted average shares29292926
Diluted EPS excluding extraordinary itemsvalue per share-0.19-0.20-0.24-0.19
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-0.19-0.20-0.24-0.19